The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I study of R04929097, an oral gamma secretase inhibitor, in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575).
Sue Richter
No relevant relationships to disclose
Elaine McWhirter
No relevant relationships to disclose
Eric Xueyu Chen
No relevant relationships to disclose
Ben Tran
No relevant relationships to disclose
Sebastien J. Hotte
No relevant relationships to disclose
Anastasios Stathis
No relevant relationships to disclose
Hal W. Hirte
No relevant relationships to disclose
Albiruni R.A. Razak
No relevant relationships to disclose
Anne Laughlin
No relevant relationships to disclose
Lisa Wang
No relevant relationships to disclose
Kristina Battista
No relevant relationships to disclose
Lee-Anne Stayner
No relevant relationships to disclose
S. Percy Ivy
No relevant relationships to disclose
Malcolm J. Moore
No relevant relationships to disclose
Amit M. Oza
No relevant relationships to disclose
Lillian L. Siu
Research Funding - Research Funding
Philippe Bedard
Honoraria - HONORARIA
Research Funding - Research Funding